RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD E72.2ORPHA:247525CTLN1

Citrullinaemia Type 1

Citrullinaemia type 1 is a rare inherited urea cycle disorder caused by changes in the ASS1 gene. The body cannot clear ammonia properly, so it builds up in the blood and can harm the brain, often within the first days of life. Care includes a low-protein diet, medicines that help remove ammonia, and an emergency plan for illness. Some people are considered for liver transplant.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

42
Articles
1
Trials
Data refreshed
26 September 2026
Loading...

Common Questions

What is Citrullinaemia Type 1?

Citrullinaemia type 1 is a rare inherited urea cycle disorder caused by changes in the ASS1 gene. The body cannot clear ammonia properly, so it builds up in the blood and can harm the brain, often within the first days of life. Care includes a low-protein diet, medicines that help remove ammonia, and an emergency plan for illness. Some people are considered for liver transplant.

How many clinical trials are available for Citrullinaemia Type 1?

RareWays currently indexes 1 clinical trial for Citrullinaemia Type 1. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Citrullinaemia Type 1 come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Citrullinaemia Type 1.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.